Patents by Inventor Carol Ann Winslow

Carol Ann Winslow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors
    Patent number: 8097621
    Abstract: This invention relates to compounds of formula (I)
    Type: Grant
    Filed: June 10, 2009
    Date of Patent: January 17, 2012
    Assignee: Pfizer Inc.
    Inventors: Andrew Simon Bell, David Graham Brown, Kevin Dack, David Nathan Abraham Fox, Ian Roger Marsh, Andrew Ian Morrell, Michael John Palmer, Carol Ann Winslow
  • Novel Pharmaceuticals
    Publication number: 20090247539
    Abstract: This invention relates to compounds of formula (I)
    Type: Application
    Filed: June 10, 2009
    Publication date: October 1, 2009
    Inventors: Andrew Simon Bell, David Graham Brown, Kevin Dack, David Nathan Abraham Fox, Ian Roger Marsh, Andrew Ian Morrell, Michael John Palmer, Carol Ann Winslow
  • Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
    Patent number: 7572799
    Abstract: This invention relates to compounds of formula (I)
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: August 11, 2009
    Assignee: Pfizer Inc
    Inventors: Andrew Simon Bell, David Graham Brown, Kevin Dack, David Nathan Abraham Fox, Ian Roger Marsh, Andrew Ian Morrell, Michael John Palmer, Carol Ann Winslow
  • Pyrazolo[4,3-D]pyrimidines
    Patent number: 7569572
    Abstract: This invention relates to compounds of formula (I).
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: August 4, 2009
    Assignee: Pfizer Inc
    Inventors: Andrew Simon Bell, David Graham Brown, David Nathan Abraham Fox, Ian Roger Marsh, Andrew Ian Morrell, Dafydd Rhys Owen, Michael John Palmer, Carol Ann Winslow, Hwang Fun Lu, Thomas Edward Rogers
  • Pyrazolo[4,3-D]Pyrimidines
    Publication number: 20080293697
    Abstract: This invention relates to compounds of formula (I).
    Type: Application
    Filed: March 30, 2005
    Publication date: November 27, 2008
    Inventors: Andrew Simon Bell, David Graham Brown, David Nathan Abraham Fox, Ian Roger Marsh, Andrew Ian Morrell, Dafydd Rhys Owen, Michael John Palmer, Carol Ann Winslow, Hwang Fun Lu, Thomas Edward Rogers
  • Substituted pyrazolo[4,3-d]pyrimidines and their use as PDE-5 inhibitors
    Patent number: 7262192
    Abstract: The present invention comprises a class of 5,7-diaminopyrazolo[4,3-d]pyrimidine compounds. These compounds are useful as phosphodiesterase type 5 inhibitors. The present invention further comprises compositions containing the compounds use of the compounds and compositions to treat hypertension and other conditions, processes for the preparation of the compounds, and intermediates used in the preparation of the compounds.
    Type: Grant
    Filed: April 29, 2004
    Date of Patent: August 28, 2007
    Assignee: Pfizer Inc.
    Inventors: Andrew Simon Bell, David Graham Brown, David Nathan Abraham Fox, Ian Roger Marsh, Andrew Ian Morrell, Michael John Palmer, Carol Ann Winslow